English | 繁體

Search in the results

UM

Browse/Search Results:  1-9 of 9 Help

Selected(0)Clear Items/Page:    Sort:
Pathogenic variants in human DNA damage repair genes mostly arose in recent human history Journal article
Zhao, Bojin, Li, Jiaheng, Sinha, Siddharth, Qin, Zixin, Kou, Si Hoi, Xiao, Fengxia, Lei, Huijun, Chen, Tianhui, Cao, Wenming, Ding, Xiaofan, Wang, San Ming. Pathogenic variants in human DNA damage repair genes mostly arose in recent human history[J]. BMC Cancer, 2024, 24(1), 415.
Authors:  Zhao, Bojin;  Li, Jiaheng;  Sinha, Siddharth;  Qin, Zixin;  Kou, Si Hoi; et al.
Favorite | TC[WOS]:3 TC[Scopus]:3  IF:3.4/3.8 | Submit date：2024/05/16
Archaeological  Dna Damage Repair  Evolutionary Origin  Pathogenic Variants  Phylogenetic  
Core promoter mutation contributes to abnormal gene expression in bladder cancer Journal article
Teng Huang, Jiaheng Li, San Ming Wang. Core promoter mutation contributes to abnormal gene expression in bladder cancer[J]. BMC Cancer, 2022, 22(1), 68.
Authors:  Teng Huang;  Jiaheng Li;  San Ming Wang
Favorite | TC[WOS]:6 TC[Scopus]:6  IF:3.4/3.8 | Submit date：2022/05/13
Bladder Cancer  Core Promoter  Gene Expression  Mutation  
Emergence of spatio-temporal variations in chemotherapeutic drug efficacy: in-vitro and in-Silico 3D tumour spheroid studies Journal article
Sheraton, M. V., Chiew, G. G.Y., Melnikov, V., Tan, E. Y., Luo, Kathy Qian, Verma, N., Sloot, P. M.A.. Emergence of spatio-temporal variations in chemotherapeutic drug efficacy: in-vitro and in-Silico 3D tumour spheroid studies[J]. BMC Cancer, 2020, 20(1), 1201 (1-16).
Authors:  Sheraton, M. V.;  Chiew, G. G.Y.;  Melnikov, V.;  Tan, E. Y.;  Luo, Kathy Qian; et al.
Favorite | TC[WOS]:7 TC[Scopus]:9  IF:3.4/3.8 | Submit date：2021/03/02
Cytotoxicity  Mitotic Spindle Stabilization  Pharmacodynamics  Pharmacokinetics  Reaction-diffusion Model  
Emergence of spatio-temporal variations in chemotherapeutic drug efficacy: in-vitro and in-Silico 3D tumour spheroid studies Journal article
Sheraton, M.V., Chiew, GGY, Melnikov, V., Tan, E.Y., Luo, K.Q., Verma, N., Sloot, P.M.A.. Emergence of spatio-temporal variations in chemotherapeutic drug efficacy: in-vitro and in-Silico 3D tumour spheroid studies[J]. BMC Cancer, 2020, 20(1), 1201 (2020).
Authors:  Sheraton, M.V.;  Chiew, GGY;  Melnikov, V.;  Tan, E.Y.;  Luo, K.Q.; et al.
Favorite | TC[WOS]:7 TC[Scopus]:9  IF:3.4/3.8 | Submit date：2022/08/26
Reaction-diffusion Model  Pharmacokinetics  Pharmacodynamics  Mitotic Spindle Stabilization  Cytotoxicity  
Granulin-epithelin precursor interacts with 78-kDa glucose-regulated protein in hepatocellular carcinoma. Journal article
Yip, C. W., Lam, C. Y. , Poon, C. W., Cheung, T. T., Cheung, P. F. Y., Fung, S. W. , Wang, X. Q., Leung, I. C. Y., Ng, L. W. C., Lo, C. M., Tsao, G. S. W., Cheung, S. T.. Granulin-epithelin precursor interacts with 78-kDa glucose-regulated protein in hepatocellular carcinoma.[J]. BMC Cancer, 2017, 409---.
Authors:  Yip, C. W.;  Lam, C. Y. ;  Poon, C. W.;  Cheung, T. T.;  Cheung, P. F. Y.; et al.
Favorite |   IF:3.4/3.8 | Submit date：2022/08/31
78-kDa glucose-regulated protein  Granulin-epithelin precursor  Hepatocellular carcinoma  Mass spectrometry  Protein interaction  
Granulin-epithelin precursor interacts with 78-kDa glucose-regulated protein in hepatocellular carcinoma Journal article
Chi Wai Yip, Ching Yan Lam, Terence C. W. Poon, Tan To Cheung, Phyllis F. Y. Cheung, Sze Wai Fung, Xiao Qi Wang, Idy C. Y. Leung, Linda W. C. Ng, Chung Mau Lo, George S. W. Tsao, Siu Tim Cheung. Granulin-epithelin precursor interacts with 78-kDa glucose-regulated protein in hepatocellular carcinoma[J]. BMC CANCER, 2017, 17.
Authors:  Chi Wai Yip;  Ching Yan Lam;  Terence C. W. Poon;  Tan To Cheung;  Phyllis F. Y. Cheung; et al.
Favorite | TC[WOS]:8 TC[Scopus]:9  IF:3.4/3.8 | Submit date：2018/10/30
Granulin-epithelin Precursor  78-kda Glucose-regulated Protein  Hepatocellular Carcinoma  Mass Spectrometry  Protein Interaction  
Family-specific, novel, deleterious germline variants provide a rich resource to identify genetic predispositions for BRCAx familial breast cancer Journal article
Wang, S. M.. Family-specific, novel, deleterious germline variants provide a rich resource to identify genetic predispositions for BRCAx familial breast cancer[J]. BMC Cancer, 2014, 470-481.
Authors:  Wang, S. M.
Favorite | TC[WOS]:14 TC[Scopus]:15  IF:3.4/3.8 | Submit date：2022/07/27
Brcax  Familial Breast Cancer  Predisposition  Exome Sequencing  
Genome instability in blood cells of a BRCA1+ breast cancer family Journal article
Wang, S. M.. Genome instability in blood cells of a BRCA1+ breast cancer family[J]. BMC Cancer, 2014, 342-352.
Authors:  Wang, S. M.
Favorite | TC[WOS]:6 TC[Scopus]:8  IF:3.4/3.8 | Submit date：2022/07/27
Brca1 Mutation  Gremline  Genome Instability  Familial  
Post-diagnosis hemoglobin change associates with overall survival of multiple malignancies - results from a 14-year hospital-based cohort of lung, breast, colorectal, and liver cancers Journal article
Wan S., Lai Y., Myers R.E., Li B., Palazzo J.P., Burkart A.L., Chen G., Xing J., Yang H.. Post-diagnosis hemoglobin change associates with overall survival of multiple malignancies - results from a 14-year hospital-based cohort of lung, breast, colorectal, and liver cancers[J]. BMC Cancer, 2013, 13.
Authors:  Wan S.;  Lai Y.;  Myers R.E.;  Li B.;  Palazzo J.P.; et al.
Favorite | TC[WOS]:22 TC[Scopus]:23 | Submit date：2018/12/21
Hemoglobin  Prognosis  Survival